• NADPH oxidase inhibitor development for diabetic nephropathy through water tank model

• Lee Hye-Eun

• Shim Seung-Hwan, Choi Yong-Seok, Bae Yun-Soo

• Kidney Research and Clinical Practice   2022  Volume.41  No.0 89 ~ 98

• Adenosine receptors as emerging therapeutic targets for diabetic kidney disease

• Pak Eun-Seon

• Cha Jin-Joo, Cha Dae-Ryong, Kanasaki Keizo, Ha Hun-Joo

• Kidney Research and Clinical Practice   2022  Volume.41  No.0 74 ~ 88

• Diabetic kidney disease treatment: new perspectives

• Tong Li-Li

• Adler Sharon G.

• Kidney Research and Clinical Practice   2022  Volume.41  No.0 63 ~ 73

• Novel biomarkers for diabetic kidney disease

• Jung Chan-Young

• Yoo Tae-Hyun

• Kidney Research and Clinical Practice   2022  Volume.41  No.0 46 ~ 62

• Exploring molecular targets in diabetic kidney disease

• Maruno Sayako

• Tanaka Tetsuhiro, Nangaku Masaomi

• Kidney Research and Clinical Practice   2022  Volume.41  No.0 33 ~ 45

• Diabetic kidney disease, revisited: where do we stand?

• Cha Dae-Ryong

• Kidney Research and Clinical Practice   2022  Volume.41  No.0 31 ~ 32

• Korean Society of Nephrology 2022 Recommendations on controversial issues in diagnosis and managemen...

• Lee Yeon-Hee

• Yoo Kyung-Don, Baek Seon-Ha, Kim Yang-Gyun, Kim Hyo-Jin, Ryu Ji-Young, Paek Jin-Hyuk, Suh ...

• Kidney Research and Clinical Practice   2022  Volume.41  No.0 1 ~ 30